Quick Answer
WEST PHARMACEUTICAL SERVICES INC reported Stockholders Equity of $3.18 billion for the year ending 2025.
- WEST PHARMACEUTICAL SERVICES INC showed an increase of +18.4% in Stockholders Equity from 2024 to 2025.
- This data is from WEST PHARMACEUTICAL SERVICES INC's annual report (Form 10-K), filed with the SEC on February 17, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2019: $1.37 billion | Q2 2019: $1.45 billion | Q3 2019: $1.49 billion | Q1 2020: $1.49 billion | Q2 2020: $1.61 billion | Q3 2020: $1.72 billion | Q1 2021: $1.83 billion | Q2 2021: $2.03 billion | Q3 2021: $2.20 billion | Q1 2022: $2.33 billion | Q2 2022: $2.42 billion | Q3 2022: $2.47 billion | Q1 2023: $2.78 billion | Q2 2023: $2.75 billion | Q3 2023: $2.87 billion | Q1 2024: $2.68 billion | Q2 2024: $2.58 billion | Q3 2024: $2.75 billion | Q1 2025: $2.68 billion | Q2 2025: $2.93 billion | Q3 2025: $3.05 billion.
- Over the full 9 years of available data (2017 to 2025), WEST PHARMACEUTICAL SERVICES INC's Stockholders Equity has grown by 148.1%.
- Historical annual values: Fiscal year 2025: $3.18 billion | Fiscal year 2024: $2.68 billion | Fiscal year 2023: $2.88 billion | Fiscal year 2022: $2.68 billion | Fiscal year 2021: $2.34 billion | Fiscal year 2020: $1.85 billion | Fiscal year 2019: $1.57 billion | Fiscal year 2018: $1.40 billion | Fiscal year 2017: $1.28 billion.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: